Comparative Pharmacology
Head-to-head clinical analysis: POTASSIUM ACETATE versus POTASSIUM CHLORIDE 0 11 IN DEXTROSE 5 IN PLASTIC CONTAINER.
Head-to-head clinical analysis: POTASSIUM ACETATE versus POTASSIUM CHLORIDE 0 11 IN DEXTROSE 5 IN PLASTIC CONTAINER.
POTASSIUM ACETATE vs POTASSIUM CHLORIDE 0.11% IN DEXTROSE 5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Potassium acetate provides potassium ions, which are essential for maintaining intracellular ionic balance, nerve conduction, muscle contraction, and acid-base equilibrium. It acts as a potassium replenisher and can also be used to alkalinize urine by converting to bicarbonate.
Potassium is the major intracellular cation, essential for maintaining cellular membrane potential, nerve impulse transmission, and muscle contraction. Dextrose provides caloric supplementation.
Intravenous, 10-20 mEq/h, maximum infusion rate 20 mEq/h, not to exceed 150 mEq/day.
Intravenous infusion at a rate not exceeding 10 mEq/h (using 0.11% potassium chloride in 5% dextrose), typically 10-20 mEq over 4-6 hours for mild hypokalemia, with a maximum concentration of 40 mEq/L via peripheral line.
None Documented
None Documented
Not applicable as potassium is not eliminated by first-order kinetics; plasma concentration reflects body stores and renal function.
Potassium has no true elimination half-life as it is homeostatically regulated; the terminal half-life of a potassium load is approximately 8-12 hours in healthy individuals, but this is highly variable and dependent on renal function, aldosterone status, and body stores. In anuric patients, potassium clearance is minimal, and dangerous accumulation can occur within hours.
Primarily renal (>90%) as potassium ions; minimal biliary/fecal.
Primarily renal; >90% of potassium is excreted by the kidneys, with approximately 10% lost in feces. In steady state, urinary potassium excretion matches dietary intake (typically 40-120 mEq/day). Dextrose is completely metabolized; unchanged dextrose excretion is negligible (<1% renal) in normoglycemic individuals.
Category C
Category C
Electrolyte Supplement
Electrolyte Supplement